We believe in a world where everyone can access the medicines and healthcare products they need to lead healthy lives.
Our innovative finance tools enable manufacturers and procurers to enter into partnerships that increase access to medical products for people who need them.
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
New malaria technologies are tackling the problem of insecticide resistance in mosquitos. Dr. Tom McLean from IVCC discusses how to get these new tools to the people who need them.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.